title: The use of propofol as a sedative agent in gastrointestinal endoscopy: a meta-analysis.
abstract: OBJECTIVE
  To assess the efficacy and safety of propofol sedation for gastrointestinal endoscopy, we conducted a meta-analysis of randomized controlled trials (RCTs) comparing propofol with traditional sedative agents.
  
  
  METHODS
  RCTs comparing the effects of propofol and traditional sedative agents during gastrointestinal endoscopy were found on MEDLINE, the Cochrane Central Register of Controlled Trials, and EMBASE. Cardiopulmonary complications (i.e., hypoxia, hypotension, arrhythmia, and apnea) and sedation profiles were assessed.
  
  
  RESULTS
  Twenty-two original RCTs investigating a total of 1,798 patients, of whom 912 received propofol only and 886 received traditional sedative agents only, met the inclusion criteria. Propofol use was associated with shorter recovery (13 studies, 1,165 patients; WMD -19.75; 95% CI -27.65, 11.86) and discharge times (seven studies, 471 patients; WMD -29.48; 95% CI -44.13, -14.83), higher post-anesthesia recovery scores (four studies, 503 patients; WMD 2.03; 95% CI 1.59, 2.46), better sedation (nine studies, 592 patients; OR 4.78; 95% CI 2.56, 8.93), and greater patient cooperation (six studies, 709 patients; WMD 1.27; 95% CI 0.53, 2.02), as well as more local pain on injection (six studies, 547 patients; OR 10.19; 95% CI 3.93, 26.39). Effects of propofol on cardiopulmonary complications, procedure duration, amnesia, pain during endoscopy, and patient satisfaction were not found to be significantly different from those of traditional sedative agents.
  
  
  CONCLUSIONS
  Propofol is safe and effective for gastrointestinal endoscopy procedures and is associated with shorter recovery and discharge periods, higher post-anesthesia recovery scores, better sedation, and greater patient cooperation than traditional sedation, without an increase in cardiopulmonary complications. Care should be taken when extrapolating our results to specific practice settings and high-risk patient subgroups.
authors: Department of Gastrointestinal Surgery, Subei People's Hospital of Jiangsu Province (Clinical Medical College of Yangzhou University), Yangzhou, Jiangsu Province, People's Republic of China.
authors: Daorong
authors: D
authors: Wang
authors: Chaowu
authors: C
authors: Chen
authors: Jie
authors: J
authors: Chen
authors: Yaxiang
authors: Y
authors: Xu
authors: Lu
authors: L
authors: Wang
authors: Zhen
authors: Z
authors: Zhu
authors: Denghao
authors: D
authors: Deng
authors: Juan
authors: J
authors: Chen
authors: Aihua
authors: A
authors: Long
authors: Dong
authors: D
authors: Tang
authors: Jun
authors: J
authors: Liu
mesh_terms: D000328:Adult; D000368:Aged; D000771:Anesthesia, Intravenous / Q000523:psychology; D001049:Apnea / Q000139:chemically induced / Q000503:physiopathology; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000503:physiopathology; D016099:Endoscopy, Gastrointestinal; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D007022:Hypotension / Q000139:chemically induced / Q000503:physiopathology; D000860:Hypoxia / Q000139:chemically induced / Q000503:physiopathology; D007902:Length of Stay; D008875:Middle Aged; D061646:Operative Time; D010146:Pain / Q000503:physiopathology / Q000517:prevention & control* / Q000523:psychology; D010147:Pain Measurement / Q000523:psychology; D010349:Patient Compliance / Q000523:psychology; D017060:Patient Satisfaction; D015742:Propofol / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D006993:Hypnotics and Sedatives; D015742:Propofol